Astrana Health, Inc. (ASTH)
USD 35.04
(-1.35%)
USD 35.04
(-1.35%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 60.71 Million USD | 34.42% |
| 2022 | 45.17 Million USD | -34.46% |
| 2021 | 68.92 Million USD | 390.18% |
| 2020 | -23.75 Million USD | -268.26% |
| 2019 | 14.11 Million USD | 30.29% |
| 2018 | 10.83 Million USD | -58.01% |
| 2017 | 25.8 Million USD | 0.0% |
| 2015 | -9.34 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 14.83 Million USD | 20.06% |
| 2024 Q2 | 19.17 Million USD | 29.23% |
| 2023 Q1 | 13.13 Million USD | 605.08% |
| 2023 Q4 | 12.35 Million USD | -43.99% |
| 2023 Q2 | 13.17 Million USD | 0.29% |
| 2023 Q3 | 22.05 Million USD | 67.49% |
| 2023 FY | 60.71 Million USD | 34.42% |
| 2022 Q2 | 11.39 Million USD | -20.09% |
| 2022 FY | 45.17 Million USD | -34.46% |
| 2022 Q4 | -2.6 Million USD | -110.01% |
| 2022 Q3 | 25.98 Million USD | 127.97% |
| 2022 Q1 | 14.26 Million USD | 3.59% |
| 2021 Q4 | 13.77 Million USD | -59.83% |
| 2021 Q2 | 12.65 Million USD | 0.0% |
| 2021 Q3 | 34.27 Million USD | 170.81% |
| 2021 FY | 68.92 Million USD | 390.18% |
| 2020 FY | -23.75 Million USD | -268.26% |
| 2019 FY | 14.11 Million USD | 30.29% |
| 2018 FY | 10.83 Million USD | -58.01% |
| 2017 FY | 25.8 Million USD | 0.0% |
| 2015 FY | -9.34 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | -21.66 Million USD | 380.228% |
| Addus HomeCare Corporation | 62.51 Million USD | 2.878% |
| AirSculpt Technologies, Inc. | -4.47 Million USD | 1455.593% |
| Amedisys, Inc. | -9.74 Million USD | 722.93% |
| American Oncology Network, Inc. | -5.54 Million USD | 1195.579% |
| Aveanna Healthcare Holdings Inc. | -134.52 Million USD | 145.135% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 3.31 Million USD | -1731.031% |
| Cryo-Cell International, Inc. | -9.52 Million USD | 737.672% |
| Cross Country Healthcare, Inc. | 72.63 Million USD | 16.403% |
| COMPASS Pathways plc | -118.46 Million USD | 151.254% |
| DocGo Inc. | 6.85 Million USD | -785.287% |
| The Ensign Group, Inc. | 209.39 Million USD | 71.004% |
| Healthcare Services Group, Inc. | 38.38 Million USD | -58.175% |
| InnovAge Holding Corp. | -21.33 Million USD | 384.549% |
| Assure Holdings Corp. | -26.07 Million USD | 332.828% |
| The Joint Corp. | -9.75 Million USD | 722.598% |
| LifeStance Health Group, Inc. | -186.26 Million USD | 132.598% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.6 Million USD | 489.142% |
| ModivCare Inc. | -204.46 Million USD | 129.696% |
| NewGenIvf Group Limited | 130.19 Thousand USD | -46536.148% |
| Novo Integrated Sciences, Inc. | -13.21 Million USD | 559.471% |
| Option Care Health, Inc. | 267.09 Million USD | 77.267% |
| P3 Health Partners Inc. | -57.77 Million USD | 205.096% |
| P3 Health Partners Inc. | -57.77 Million USD | 205.096% |
| The Pennant Group, Inc. | 13.37 Million USD | -353.823% |
| Surgery Partners, Inc. | -11.9 Million USD | 610.227% |
| Syra Health Corp. Class A Common Stock | -2.93 Million USD | 2166.369% |
| Talkspace, Inc. | -19.18 Million USD | 416.531% |
| Talkspace, Inc. | -19.18 Million USD | 416.531% |
| The Oncology Institute, Inc. | -83.06 Million USD | 173.093% |
| The Oncology Institute, Inc. | -83.06 Million USD | 173.093% |